FAMOTIDINE 10MG

FAMOTIDINE 10MG was reported 108 times

FAMOTIDINE 10MG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LUNG ASSIST DEVICE THERAPY 1 0.0161
1 GASTRIC PNEUMATOSIS 1 0.0141
2 PRODUCT STERILITY LACKING 1 0.0119
3 GASTRIC MUCOSA ERYTHEMA 1 0.0030
4 DRUG EFFECT FASTER THAN EXPECTED 1 0.0030
5 PORTAL VENOUS GAS 1 0.0028
6 ERYTHROMELALGIA 1 0.0027
7 COLON CANCER STAGE III 1 0.0026
8 MANUFACTURING ISSUE 1 0.0022
9 FINGER AMPUTATION 1 0.0014
10 LABORATORY TEST INTERFERENCE 1 0.0013
11 TONGUE PRURITUS 1 0.0012
12 PRODUCT CLOSURE REMOVAL DIFFICULT 1 0.0010
13 GALLBLADDER ENLARGEMENT 1 0.0009
14 BILIARY DILATATION 1 0.0007
15 BRONCHIAL DISORDER 1 0.0006
16 RENAL HAEMORRHAGE 1 0.0005
17 VASCULAR STENT THROMBOSIS 1 0.0005
18 PULSELESS ELECTRICAL ACTIVITY 2 0.0005
19 REACTION TO DRUG EXCIPIENTS 1 0.0005
20 CONTRAST MEDIA REACTION 1 0.0004
21 TRANSPLANT 1 0.0004
22 EMERGENCY CARE 1 0.0003
23 TONGUE DISCOMFORT 1 0.0002
24 MENINGITIS ASEPTIC 1 0.0002
25 ABDOMINAL TENDERNESS 1 0.0002
26 AMMONIA INCREASED 1 0.0002
27 PRODUCT COLOUR ISSUE 1 0.0002
28 BLOOD LACTIC ACID INCREASED 1 0.0002
29 ANORECTAL DISCOMFORT 1 0.0002
30 FOOD POISONING 1 0.0002
31 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
32 GANGRENE 1 0.0002
33 CHOLANGITIS 1 0.0002
34 PRODUCT FORMULATION ISSUE 1 0.0002
35 TORSADE DE POINTES 1 0.0001
36 CYANOSIS 2 0.0001
37 MUSCLE DISORDER 1 0.0001
38 FACIAL PARALYSIS 1 0.0001
39 THERAPY CESSATION 6 0.0001
40 UROSEPSIS 1 0.0001
41 RECALLED PRODUCT ADMINISTERED 1 0.0001
42 HOSPICE CARE 1 0.0001
43 BRAIN INJURY 1 0.0001
44 APHASIA 3 0.0001
45 EMPHYSEMA 1 0.0001
46 HEAD INJURY 3 0.0001
47 HEPATOTOXICITY 2 0.0001
48 NEPHROPATHY TOXIC 1 0.0001
49 VASCULITIS 1 0.0001
50 COVID-19 PNEUMONIA 1 0.0001
51 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
52 HYPOPHAGIA 2 0.0001
53 ORAL CANDIDIASIS 1 0.0001
54 ACUTE HEPATIC FAILURE 1 0.0001
55 ORAL DISCOMFORT 1 0.0001
56 APHONIA 1 0.0001
57 SUBDURAL HAEMATOMA 1 0.0001
58 ABSCESS 1 0.0001
59 SENSORY DISTURBANCE 1 0.0001
60 PHOTOSENSITIVITY REACTION 1 0.0001
61 MUSCULOSKELETAL DISCOMFORT 1 0.0001
62 COLD SWEAT 1 0.0001
63 GALLBLADDER DISORDER 1 0.0001
64 ANAPHYLACTIC REACTION 3 0.0001
65 HEPATIC STEATOSIS 1 0.0001
66 BACTERIAL INFECTION 1 0.0001
67 DYSARTHRIA 2 0.0001
68 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
69 CHOKING 1 0.0001
70 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
71 POOR QUALITY SLEEP 1 0.0000
72 FAECES DISCOLOURED 1 0.0000
73 MELAENA 1 0.0000
74 GLOSSODYNIA 1 0.0000
75 ORAL PAIN 1 0.0000
76 TINNITUS 2 0.0000
77 NEURALGIA 1 0.0000
78 ENCEPHALOPATHY 1 0.0000
79 HALLUCINATION 3 0.0000
80 HEPATITIS 1 0.0000
81 MUCOSAL INFLAMMATION 1 0.0000
82 ANHEDONIA 1 0.0000
83 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
84 JAUNDICE 1 0.0000
85 THROAT TIGHTNESS 1 0.0000
86 OXYGEN SATURATION DECREASED 2 0.0000
87 FLATULENCE 2 0.0000
88 RED BLOOD CELL COUNT DECREASED 1 0.0000
89 LETHARGY 2 0.0000
90 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
91 CHILLS 4 0.0000
92 URINARY INCONTINENCE 1 0.0000
93 BLOOD POTASSIUM DECREASED 1 0.0000
94 LACRIMATION INCREASED 1 0.0000
95 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
96 DRUG-INDUCED LIVER INJURY 1 0.0000
97 EYE DISORDER 1 0.0000
98 GASTRIC DISORDER 1 0.0000
99 BURNING SENSATION 2 0.0000
100 PLATELET COUNT DECREASED 3 0.0000
101 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
102 PANIC ATTACK 1 0.0000
103 DISORIENTATION 1 0.0000
104 CARDIAC ARREST 2 0.0000
105 CARDIO-RESPIRATORY ARREST 1 0.0000
106 RENAL FAILURE ACUTE 1 0.0000
107 LIVER DISORDER 1 0.0000
108 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
109 ARRHYTHMIA 1 0.0000
110 NEUROPATHY PERIPHERAL 2 0.0000
111 DISEASE RECURRENCE 1 0.0000
112 INFECTION 3 0.0000
113 HYPOGLYCAEMIA 1 0.0000
114 HEART RATE INCREASED 2 0.0000
115 SYNCOPE 2 0.0000
116 BLOOD PRESSURE INCREASED 3 0.0000
117 INFLAMMATION 1 0.0000
118 BRADYCARDIA 1 0.0000
119 RASH PRURITIC 1 0.0000
120 BLISTER 1 0.0000
121 MYALGIA 3 0.0000
122 PRODUCT SUBSTITUTION ISSUE 1 0.0000
123 SEIZURE 2 0.0000
124 PALPITATIONS 2 0.0000
125 DISEASE PROGRESSION 2 0.0000
126 IRRITABILITY 1 0.0000
127 STOMATITIS 1 0.0000
128 DISCOMFORT 1 0.0000
129 FEELING HOT 1 0.0000
130 HYPERHIDROSIS 2 0.0000
131 PRODUCT DOSE OMISSION 1 0.0000
132 INFUSION RELATED REACTION 1 0.0000
133 PRODUCT QUALITY ISSUE 2 0.0000
134 ABDOMINAL PAIN UPPER 3 0.0000
135 MEMORY IMPAIRMENT 2 0.0000
136 THERAPY INTERRUPTED 1 0.0000
137 DEATH 12 0.0000
138 PERIPHERAL SWELLING 2 0.0000
139 NAUSEA 10 0.0000
140 DRY MOUTH 1 0.0000
141 TREATMENT FAILURE 1 0.0000
142 TREMOR 2 0.0000
143 SKIN EXFOLIATION 1 0.0000
144 BALANCE DISORDER 1 0.0000
145 TACHYCARDIA 1 0.0000
146 GASTROINTESTINAL DISORDER 1 0.0000
147 CHEST PAIN 2 0.0000
148 HYPERSENSITIVITY 2 0.0000
149 CARDIAC DISORDER 1 0.0000
150 PRODUCT USE ISSUE 2 0.0000
151 VOMITING 5 0.0000
152 DYSPHAGIA 1 0.0000
153 PULMONARY EMBOLISM 1 0.0000
154 DRUG INTOLERANCE 1 0.0000
155 ATRIAL FIBRILLATION 1 0.0000
156 ALOPECIA 2 0.0000
157 DIZZINESS 5 0.0000
158 HYPOTENSION 2 0.0000
159 SOMNOLENCE 2 0.0000
160 CHEST DISCOMFORT 1 0.0000
161 HAEMOGLOBIN DECREASED 1 0.0000
162 DIARRHOEA 6 0.0000
163 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
164 CONSTIPATION 2 0.0000
165 FALL 3 0.0000
166 DYSPNOEA 5 0.0000
167 MUSCULAR WEAKNESS 1 0.0000
168 PYREXIA 3 0.0000
169 DECREASED APPETITE 2 0.0000
170 BACK PAIN 2 0.0000
171 EMOTIONAL DISTRESS 1 0.0000
172 DEHYDRATION 1 0.0000
173 DRY SKIN 1 0.0000
174 NEUTROPENIA 1 0.0000
175 VISION BLURRED 1 0.0000
176 WEIGHT DECREASED 2 0.0000
177 ANXIETY 2 0.0000
178 MALAISE 3 0.0000
179 PAIN IN EXTREMITY 2 0.0000
180 CONDITION AGGRAVATED 2 0.0000
181 PAIN 4 0.0000
182 PARAESTHESIA 1 0.0000
183 CONFUSIONAL STATE 1 0.0000
184 DRUG DOSE OMISSION 1 0.0000
185 URTICARIA 1 0.0000
186 ABDOMINAL DISCOMFORT 1 0.0000
187 TOXICITY TO VARIOUS AGENTS 1 0.0000
188 MUSCLE SPASMS 1 0.0000
189 ASTHENIA 2 0.0000
190 BLOOD GLUCOSE INCREASED 1 0.0000
191 GAIT DISTURBANCE 1 0.0000
192 PRURITUS 2 0.0000
193 HEADACHE 3 0.0000
194 DEPRESSION 1 0.0000
195 ABDOMINAL PAIN 1 0.0000
196 FATIGUE 3 0.0000
197 INSOMNIA 1 0.0000
198 COUGH 1 0.0000
199 OFF LABEL USE 3 0.0000
200 ARTHRALGIA 1 0.0000
201 RASH 1 0.0000
202 DRUG INEFFECTIVE 1 0.0000